Mometasone La Colina (Mometasone Furoate Anhydrous)

Mometasone furoate, the active ingredient in Mometasone La Colina, is a corticosteroid presented as a nasal spray for intranasal use. It treats allergic rhinitis by reducing inflammation in the nasal mucosa of adults and children. GNH USA supplies Mometasone La Colina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a nasal corticosteroid used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis (seasonal): reduces nasal congestion, sneezing, itching and rhinorrhea. Allergic rhinitis (perennial): provides sustained relief of chronic nasal inflammation. Nasal polyposis (adjunct): may help shrink polyps and improve nasal airflow when used as directed.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleeds). - Throat irritation or dryness. - Altered taste or bitter taste. - Cough.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe or persistent epistaxis. - Allergic reactions including anaphylaxis. - Vision changes such as cataracts or glaucoma. - Adrenal suppression with prolonged high‑dose use. - Opportunistic fungal infection of the nasal passages.

Before using Mometasone furoate nasal spray, consider the following safety measures.

Use only as prescribed: follow the prescriber’s instructions for frequency and duration. Avoid use in untreated nasal infections: treat bacterial or fungal infections first. Monitor for systemic corticosteroid effects: watch for signs of adrenal suppression or growth retardation in children. Caution in patients with glaucoma or cataracts: inform the prescriber of any eye conditions. Do not use in children under the recommended age without medical guidance. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Mometasone furoate may interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic exposure. - Systemic corticosteroids: additive immunosuppressive effects. - Ritonavir or other protease inhibitors: can raise mometasone levels.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., fluconazole): may modestly increase exposure. - Certain antibiotics (e.g., erythromycin): monitor for enhanced local effects.